Search results for "Prescriptions"
Study finds frequent use of medications for which depression is an adverse effect
Overall estimated prevalence of use of medications with depression as a potential adverse effect was 37.2%, increasing from 35.0% in 2005 and 2006 to 38.4% in 2013 and 2014.
https://immattersacp.org/weekly/archives/2018/06/19/2.htm
19 Jun 2018
Experts cover common COVID-19 challenges
A recent ACP/Annals of Internal Medicine forum on COVID-19 considered the timing of vaccination, outpatient treatment, and pre-exposure prophylaxis.
https://immattersacp.org/archives/2022/10/experts-cover-common-covid-19-challenges.htm
1 Oct 2022
Fatal overdoses may be declining in the U.S.
The number of drug overdose deaths in the U.S. appears to have dropped from 2017 to 2018, according to the latest CDC estimates, although counts have not been finalized.
https://immattersacp.org/weekly/archives/2019/07/23/5.htm
23 Jul 2019
Higher baclofen dosage associated with encephalopathy in older patients with CKD
A retrospective Canadian study compared 30-day risk for encephalopathy in older patients with chronic kidney disease (CKD) who were newly prescribed at least 20 mg of baclofen per day versus a lower dose, as well as in baclofen users versus nonusers.
https://immattersacp.org/weekly/archives/2019/11/12/4.htm
12 Nov 2019
Congress passes historic health, climate change legislation
The Inflation Reduction Act allows Medicare to negotiate some prescription drug prices for the first time and includes provisions for climate change.
https://immattersacp.org/archives/2022/10/congress-passes-historic-health-climate-change-legislation.htm
1 Oct 2022
ACP congratulates 2019 Innovation Challenge, Annals Story Slam winners
Both events were held in April at ACP's annual meeting.
https://immattersacp.org/weekly/archives/2019/05/07/6.htm
7 May 2019
Controlled substance agreements may reduce primary care visits, amid a decades-old, growing opioid crisis
Researchers retrospectively evaluated health care utilization changes among primary care patients receiving long-term opioid therapy for chronic noncancer pain who enrolled in a controlled substance agreement.
https://immattersacp.org/weekly/archives/2018/09/25/2.htm
25 Sep 2018
Anticonvulsant may increase mortality risk when coprescribed with opioids
An association was found between concomitant exposure to pregabalin in the preceding 120 days and significantly increased odds of opioid-related death versus exposure to opioids alone, a study found.
https://immattersacp.org/weekly/archives/2018/08/21/4.htm
21 Aug 2018
10% of those who use opioids account for the vast majority of use
A recent study examined a commercial database of pharmacy claims for more than 20 million privately insured adults without cancer who were continuously enrolled for at least one calendar year between 2001 and 2013 and filled at least one prescription for an opioid.
https://immattersacp.org/weekly/archives/2017/09/12/4.htm
12 Sep 2017
Short-term oral corticosteroid use common, but may pose risks
Researchers conducted a retrospective cohort study and self-controlled case series to determine the frequency of prescriptions for less than 30 days of oral corticosteroids and any association with adverse events.
https://immattersacp.org/weekly/archives/2017/04/18/4.htm
18 Apr 2017